Nippon India Nifty Pharma ETF Regular Growth | Nippon India Nifty Pharma ETF NAV Today [24.93], Performance & History

Other Index/ETF Regular Growth

3 Year Absolute Returns

86.12% ↑

NAV (₹) on 18 Jun 2026

24.93

1 Day NAV Change

0.56%

Risk Level

Very High Risk

Rating

Nippon India Nifty Pharma ETF is a Equity mutual fund categorized under ETF, offered by Nippon Life India Asset Management Ltd.. Launched on 21 Jun 2021, investors can start with a lumpsum investment ... Read more

NAV History

Fund Details

Min. SIP Amount

N/A

Inception Date

21 Jun 2021

Min. Lumpsum Amount

₹ 1,000

Fund Age

4 Yrs

AUM

₹ 1,570.17 Cr.

Benchmark

Nifty Pharma Total Return

Expense Ratio

Scheme Type

Open Ended

Exit Load

Nil%

Returns Calculator

Investment amount per month

₹1,000

Over the past

Would have become

On total investment of

*Calculation based on past performance of this fund.

Asset Allocation

AUM

₹ 1,570.17 Cr

Equity

499.81%

Money Market & Cash

0.9%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	99.95%
Treps/Reverse Repo	0.46%

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Limited	21.93%	₹ 232.13	Pharmaceuticals
Divi's Laboratories Limited	9.71%	₹ 102.77	Pharmaceuticals
Dr. Reddy's Laboratories Limited	9.35%	₹ 98.93	Pharmaceuticals
Cipla Limited	9.04%	₹ 95.73	Pharmaceuticals
Lupin Limited	6.65%	₹ 70.43	Pharmaceuticals
Torrent Pharmaceuticals Limited	5.40%	₹ 57.20	Pharmaceuticals
Laurus Labs Limited	4.98%	₹ 52.75	Pharmaceuticals
Aurobindo Pharma Limited	4.07%	₹ 43.08	Pharmaceuticals
Alkem Laboratories Limited	3.93%	₹ 41.65	Pharmaceuticals
Glenmark Pharmaceuticals Limited	3.84%	₹ 40.61	Pharmaceuticals
Biocon Limited	3.32%	₹ 35.11	Pharmaceuticals
Mankind Pharma Limited	3.03%	₹ 32.09	Pharmaceuticals
Zydus Lifesciences Limited	2.75%	₹ 29.11	Pharmaceuticals
IPCA Laboratories Limited	2.53%	₹ 26.82	Pharmaceuticals
JB Chemicals & Pharmaceuticals Limited	2.00%	₹ 21.19	Pharmaceuticals
Gland Pharma Limited	1.73%	₹ 18.30	Pharmaceuticals
Abbott India Limited	1.65%	₹ 17.48	Pharmaceuticals
Ajanta Pharma Limited	1.50%	₹ 15.92	Pharmaceuticals
Wockhardt Limited	1.34%	₹ 14.20	Pharmaceuticals
Piramal Pharma Limited	1.15%	₹ 12.19	Pharmaceuticals
Triparty Repo	0.13%	₹ 1.35	Others

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	7.76%	13.15%	11.21%	23.01%
Category returns	2.15%	4.83%	5.50%	23.62%

Fund Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject ... Read more

AMC Details

Name

Nippon Life India Asset Management Ltd.

Date of Incorporation

30 Jun 1995

CEO

Mr. Sundeep Sikka

CIO

Mr. Amit Tripathi Mr. Sailesh Raj Bhan

Type

Foreign

Address

4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai, Maharashtra, India - 400013

Website

https://www.nipponindiamf.com

[email protected]

Top Funds from Others - Index Funds/ETFs

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
ICICI Prudential Silver ETF ETF Regular	₹238.91	117.55%	222.99%	0.00%	₹15,986	0.40%	Very High
Axis Silver ETF ETF Regular	₹237.75	116.76%	222.33%	0.00%	₹2,163	0.42%	Very High
Kotak Silver ETF ETF Regular	₹23.21	117.15%	222.11%	0.00%	₹3,851	0.35%	Very High
DSP Silver ETF ETF Regular	₹230.79	117.44%	222.00%	0.00%	₹1,851	N/A	Very High
Mirae Asset Silver ETF ETF Regular	₹232.86	116.78%	221.61%	0.00%	₹1,152	0.36%	Very High
HDFC Silver ETF ETF Regular	₹228.91	116.37%	220.48%	0.00%	₹8,257	0.50%	Very High
Aditya Birla Sun Life Silver ETF ETF Regular	₹238.88	117.30%	220.32%	0.00%	₹3,176	0.35%	Very High
Nippon India Silver ETF ETF Regular	₹228.90	116.69%	220.26%	0.00%	₹32,937	N/A	Very High
UTI Silver Exchange Traded Fund ETF Regular	₹231.09	114.89%	216.16%	0.00%	₹1,480	0.59%	Very High
Mirae Asset NYSE FANG + ETF ETF Regular	₹162.99	35.11%	158.22%	219.78%	₹4,258	0.65%	Very High

Top Funds from Nippon Life India Asset Management Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Silver ETF ETF Regular	₹228.90	116.69%	220.26%	0.00%	₹32,937	N/A	Very High
Nippon India Silver ETF FOF - Direct Plan Fund of Funds Direct	₹36.66	114.19%	216.42%	0.00%	₹4,847	0.21%	Very High
Nippon India Silver ETF FOF - Direct Plan Fund of Funds Direct	₹36.66	114.19%	216.42%	0.00%	₹4,847	0.21%	Very High
Nippon India Silver ETF FOF - Direct Plan Fund of Funds Direct	₹36.66	114.19%	216.42%	0.00%	₹4,847	0.21%	Very High

FAQs

What is the current NAV of Nippon India Nifty Pharma ETF Regular Growth?

The current Net Asset Value (NAV) of Nippon India Nifty Pharma ETF Regular Growth is ₹24.93 as of 18 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of Nippon India Nifty Pharma ETF Regular Growth?

The Assets Under Management (AUM) of Nippon India Nifty Pharma ETF Regular Growth is ₹1,570.17 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of Nippon India Nifty Pharma ETF Regular Growth?

Nippon India Nifty Pharma ETF Regular Growth has delivered returns of 13.15% (1 Year), 23.01% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of Nippon India Nifty Pharma ETF Regular Growth?

Nippon India Nifty Pharma ETF Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for Nippon India Nifty Pharma ETF Regular Growth?

The minimum lumpsum investment required for Nippon India Nifty Pharma ETF Regular Growth is ₹1,000. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article